Exchange: NASDAQ·Updated 07:56 PM EDT
BNTX logo

BNTX BioNTech SE - ADR

$103.76
$0.88
(0.85%)
Today
Closed $103.76
$0.49
(0.47%)
After Hours
EarningsNov 3
Mkt Cap$26.06B
Vol626,060.00

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
38

Bearish Sentiment

How do you feel about BNTX?

Advertisement|Remove ads.